What is the ticker symbol for NeuroMetrix?

NeuroMetrix trades under the ticker NURO on NASDAQ.

What sector does NeuroMetrix operate in?

NeuroMetrix is classified in the Healthcare sector (Medical - Devices industry).

How can PortView help analyze NURO in a portfolio?

PortView shows NURO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

NeuroMetrix (NURO) Stock Analysis

NASDAQHealthcareMedical - Devices

$4.58+5.05%

1-year price historyRange $2.79 – $4.60

52-week range$4.58

$2.66$4.73

What NeuroMetrix does

NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.

Key metrics

Market cap

$9.43M

P/E (TTM)

-1.16

EPS (TTM)

$-3.96

Beta

1.83

Dividend yield

0.00%

Revenue / share

$1.54

50-day avg

$4.39

200-day avg

$4.01

52-week high

$4.73

52-week low

$2.66

CEO

Shai N. Gozani

ETFs linked to NURO

Broad-market and Healthcare sector ETFs an investor holding NeuroMetrix is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how NURO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NURO in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for NeuroMetrix?: NeuroMetrix trades under the ticker NURO on NASDAQ.
Which exchange is NURO listed on?: NURO is listed on NASDAQ.
What sector does NeuroMetrix operate in?: NeuroMetrix is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze NURO in a portfolio?: PortView shows NURO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.